Eton Pharmaceuticals (ETON) Construction in Progress (2018 - 2022)
Eton Pharmaceuticals (ETON) reported Construction in Progress of $12000.0 for Q4 2022, little changed sequentially from $12000.0 in Q1 2022.
Eton Pharmaceuticals (ETON) Construction in Progress (2018 - 2022) Analysis & Trends
Eton Pharmaceuticals (ETON) has 4 years of Construction in Progress data on file, last reported at $12000.0 in Q4 2022.
- For the quarter ending Q4 2022, Construction in Progress changed N/A year-over-year to $12000.0; the trailing twelve-month figure through Dec 2022 stood at $12000.0 (changed N/A YoY), and the FY2022 full-year result was $12000.0, changed N/A from the prior year.
- Construction in Progress was little changed at $12000.0 in Q4 2022, from $12000.0 in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $873000.0 in Q1 2019 to a low of $1000.0 in Q3 2020.
- A 4-year average of $175750.0 and a median of $10500.0 in 2019 frame the typical range for Construction in Progress.
- Peak annual rise in Construction in Progress reached 66.67% in 2020, while the deepest fall reached 99.54% in 2020.
- Tracing ETON's Construction in Progress over 4 years: stood at $492000.0 in 2018, then plunged by 98.17% to $9000.0 in 2019, then sank by 88.89% to $1000.0 in 2020, then soared by 1100.0% to $12000.0 in 2022.
- Business Quant data shows ETON's Construction in Progress at $12000.0 in Q4 2022, $12000.0 in Q1 2022, and $1000.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 12,000.00 |
| Mar 31, 2022 | 12,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Mar 31, 2019 | 873,000.00 |
| Dec 31, 2018 | 492,000.00 |